Email this article The national manufacturers of the Republic of Kazakhstan in resolving problems of production of anti-tuberculosis pharmaceuticals
- Authors: Sataeva L.G.1, Kelimkhanova S.E1, Garankina R.Y.2
-
Affiliations:
- The S.D. Asfendiarov Kazakhskiy national medical university
- The I.M. Sechenov first Moscow state medical university of Minzdrav of Russia
- Issue: Vol 22, No 3 (2016)
- Pages: 139-141
- Section: Articles
- URL: https://journals.rcsi.science/0869-2106/article/view/38329
- DOI: https://doi.org/10.18821/0869-2106-2016-22-3-139-141
- ID: 38329
Cite item
Full Text
Abstract
The article presents the possibilities of national manufacturers of pharmaceuticals to provide with medicines patients with tuberculosis in the Republic of Kazakhstan
Full Text
##article.viewOnOriginalSite##About the authors
Larisa G. Sataeva
The S.D. Asfendiarov Kazakhskiy national medical university
Email: lsataeva@mail.ru
candidate of pharmaceutical sciences, assistant professor of chair of management and marketing in health care and pharmacy 050026, Almaty, the Republic of Kazakhstan
S. E Kelimkhanova
The S.D. Asfendiarov Kazakhskiy national medical university050026, Almaty, the Republic of Kazakhstan
R. Yu Garankina
The I.M. Sechenov first Moscow state medical university of Minzdrav of Russia310115, Moscow, Russia
References
- WHO. Global Tuberculosis control. WHO Report. Geneva; 2014.
- Сатаева Л.Г., Третьякова Д., Чекотаева К.А., Келимханова С.Е., Нурпеисова Л.С. Анализ возможностей фармацевтической промышленности Республики Казахстан в совершенствовании процесса лекарственного обеспечения в стране. МедиАль. 2015; (1): 261-2.
Supplementary files
